Navigation Links
USDA's Decision Thursday on Genetically Engineered Alfalfa -- Leahy and DeFazio Warn About USDA Decision Lifting All Protections for Organic and Conventional Farmers
Date:1/27/2011

WASHINGTON, Jan. 27, 2011 /PRNewswire-USNewswire/ -- Following are the comments of Senator Patrick Leahy (D-Vt.) and Congressman Peter DeFazio (D-Ore.) on USDA's announcement Thursday that the agency will completely remove current regulations that limit use of genetically engineered (GE) alfalfa, a key commodity in dairy farming, including organic dairy farming, making alfalfa the first perennial GE crop approved for widespread planting. Leahy and DeFazio have led congressional efforts to limit the threat to organic farmers of widely introducing "Roundup Ready" genetically engineered alfalfa. The two lawmakers last June headed a letter to Agriculture Secretary Tom Vilsack, asking that alfalfa's regulated status be retained in USDA's pending rulemaking on GE alfalfa. Leahy and DeFazio also are the co-authors of the 1990 legislation that created the national organic standards and labeling program and continue to champion the growth and success of the U.S. organic industry.

Joint Statement

Of Senator Patrick Leahy (D-Vt.)

And Representative Peter DeFazio (D-Ore.)

On USDA's Decision On Genetically Engineered Alfalfa

Thursday, January 27, 2011

"This long approval process began as a search for a workable compromise, but it has ended as a surrender to business as usual for the biotech industry. USDA officials had an opportunity to address the concerns of all farmers, whether they choose to farm genetically altered crops, conventional crops, or organic crops, and to find a way for them to coexist. Instead, what we now have is a setback for the nation's organic and conventional agriculture sectors. Instead of settling this issue, USDA's decision regrettably guarantees further rounds in the courts.

"This is a big payday for the giant firms that pushed for this rollback. Unfortunately, consumers and hardworking farmers who choose not to use these genetically engineered crops will be handed the tab. Organic feed already is expensive and in short supply. This will compound that problem while creating many more.

"America's biotech industry and organic agriculture can coexist and thrive, but only if there are clear rules to referee their conflicting needs and interests."


'/>"/>
SOURCE Office of U.S. Senator Patrick Leahy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Second Edition of Biotechnology and the Federal Circuit Examines the Courts Decisions on Chemical, Biotechnology, and Pharmaceutical Patent Law Cases
2. Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately
3. Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors
4. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
5. Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
6. Report Details How States Respond to Citizens United Decision
7. Pew Faults Marine Stewardship Councils Decision
8. Responding to OCS Drilling Decision, Advocacy Group Challenges President to "Get Serious" About Energy Independence and Security
9. Industry Leaders from Blue Coat, Oracle, Polycom, Siemens and Taleo Headline SiriusDecisions Sales and Marketing Summit 2010
10. Tool identifies infection clusters; rate of T cell drop not helpful in decision to start treating HIV
11. Cautious Approach Needed Before Any Decision on EU Out-of-Quota Sugar Exports Is Taken
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets has announced the addition of the "Cancer ... Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. ... Cancer Biomarkers ... $15,737 million by 2022 from $6,521 in 2015, growing at a ... technologies segment accounted for more than half of the revenue share ...
(Date:1/19/2017)... 2017 /PRNewswire -- WuXi AppTec, a leading global ... technology platform, today announced that it has acquired ... drug discovery contract research organization (CRO). After completion ... subsidiary of WuXi, and will continue to focus ... services. The acquisition will further strengthen WuXi,s R&D ...
(Date:1/19/2017)... Berkeley, CA (PRWEB) , ... January 19, 2017 ... ... the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers ... Mail is a fully 21 CFR Part 11-compliant email client designed to provide ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
Breaking Biology Technology:
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):